Trump administration says pharma tariffs are likely weeks away; Drug companies formed the IRA Watchdogs group; Eli Lilly to raise price of Mounjaro in U.K.

Countries may develop their own vaccines amid U.S. uncertainty; FDA considers revoking Pfizer’s COVID vaccine approval for young children; Trump open to reclassifying marijuana.

Christophe Hotermans, Alexion’s head of global medical affairs, discusses the drugmaker’s latest rare disease-focused film.

The region is one of the state’s poorest. In Alamosa County, 2 in 5 residents are enrolled in Health First Colorado, the state’s Medicaid program.

OpenAI launched ChatGPT-5 on Thursday (7 August) last week, which sent out a “warning shot” across adland, according to creatives. Ross Taylor, group executive creative director at Havas Play, told ...

Health and Human Services Secretary Robert F. Kennedy Jr.’s decision to discontinue mRNA vaccine funding has scientists worried about national security. If the United States were ever to be targeted ...

AbbVie’s Skyrizi tallied the most TV impressions among pharma brands in July, rising from second in June. The psoriasis treatment achieved a share of voice (SOV) of 4.61% with 2.5 billion impressions.

In partnership with the National Psoriasis Foundation, Boehringer Ingelheim has launched a new campaign to increase awareness and education for generalized pustular psoriasis (GPP). The campaign will ...

The Museum of Public Relations has chosen the five recipients of this year’s NextGen Awards, in partnership with PRWeek, recognizing young PR pros who personify the industry’s Hidden History ...

Imagine entering a hospital lobby to the sound of beach sand crunching and distant seagulls. In the elevator is the sound of the wind and flutes. Each floor has varying sound themes. This is reality ...

Mallinckrodt hired Christiana Stamoulis away from Incyte to serve as president and CFO. WeightWatchers named SoulCycle co-founder Julie Rice as chief experience officer. Ajit Singh was appointed CEO ...

Sarepta Therapeutics disclosed new safety data, including liver injury rates, for its Duchenne muscular dystrophy gene therapy Elevidys during a webinar hosted by UCLA. The disclosure of the detailed ...